Environmental Clean Technologies Limited · ASX:ECT

Environmental Clean Technologies — Merger or Acquisition (August 2026)

18 slides from Environmental Clean Technologies's merger presentation, Aug 5, 2026

  1. Slide 1: Acquisition of Xenica: A Scalable Path to Commercial-Grade MXenes

    Acquisition of Xenica: A Scalable Path to Commercial-Grade MXenes Licence and production pathway to a supply-constrained material AUGUST 2026 ASX:ECT

  2. Slide 2: Important Notice and Disclaimers

    Disclaimer Important Notice and Disclaimers This presentation is dated 5 August 2026 has been prepared by Environmental Clean Technologies Limited (Company). Not an offer This presentation is provided for general information purposes only. This presentation does not constitute an offer, invitation,

  3. Slide 3: Executive Summary

    Executive Summary Company Overview ECT is advancing its strategy of building a diversified portfolio of high-impact, disruptive technologies, developed in collaboration with world-leading researchers Acquisition ECT is acquiring 100% of Xenica Materials Pty Ltd (Xenica) for 60m ECT shares (six month

  4. Slide 4: What ECT Is Acquiring

    What ECT Is Acquiring 100% of Xenica Materials; the rights and relationships to commercialise MXenes via FJH The Transaction ECT is acquiring 100% of Xenica Materials for 60m ECT shares (six months' voluntary escrow); subject to shareholder approval Rice University Licence Xenica holds an exclusive

  5. Slide 5: Structure & Financing

    Structure & Financing ECT to acquire 100% of Xenica, holder of an exclusive licence with Rice University to use Flash Joule Heating for the production of MXenes Acquisition Escrow Capital Use of Consideration Terms & Conditions Raise Funds 60M $12M All Consideration Shares are • Development of new s

  6. Slide 6: MXenes: The Xenica Acquisition

    MXenes: The Xenica Acquisition ASX:ECT

  7. Slide 7: What are MXenes

    What are MXenes A high-performance 2D nanomaterial at the centre of the Xenica licence Atomic Structure & Key Applications What they are • 2D nanomaterials derived from a MAX phase precursor • Highly customisable with a rare combination of properties in a single material • Standout properties includ

  8. Slide 8: Why MXenes Matter Commercially

    Why MXenes Matter Commercially Premium demand pools exist today, but reliable supply does not The commercial case High Electrical Hydrophilicity • High-value product forms, including ink, film, powder and coatings, can drop into existing product designs at a premium Conductivity Conducts electricity

  9. Slide 9: Locked by Legacy Processes

    Locked by Legacy Processes Incumbent manufacturing processes cannot scale, creating a clear opportunity for the FJH pathway Legacy Approaches CVD Hydrofluoric Acid Fluoride-Free FJH Output per batch <0.1 g 10–100 g 1–10 g ~250 g US$100+ /g Total time per batch ~15 mins–2 hrs ~48-72 hrs ~12-24 hrs 30

  10. Slide 10: Unlocking MXene Production at Scale

    Unlocking MXene Production at Scale FJH replaces a multi-day hazardous batch chemistry process with a rapid, cleaner process suited to scalable commercial supply CASE STUDY 1. Electrical pulse 2. Extreme heat 3. Synthesis Hundreds of degrees in Rapid formation while High-current pulse to heat MAX Ph

  11. Slide 11: Defence: First Target Commercial Market

    Defence: First Target Commercial Market Where strong, price inelastic demand resides › Licensing Requirements: Drexel University holds various patents over MXenes, with production for commercial Supporting Use-Cases3 use subject to licensing requirements. Xenica has identified MXenes for military en

  12. Slide 12: Scaling MXenes

    Scaling MXenes The scale-up path utilising Metallium's permitted Gator Point facility Capital-Light Model immediate access to an established, permitted FJH reactor reduces capital requirements Speed to Market established facility and operating know-how accelerate pathway to first production Initial

  13. Slide 13: Why ECT Wins Here

    Why ECT Wins Here An assembled path to market combining IP, manufacturing access and scale into a practical route to first product ✓ SECURED LICENCE · PROCES S Rice University Exclusive licence to FJH MXene synthesis - the foundation of the production pathway PROCES S AD VANTAGE FJH: minutes, not da

  14. Slide 14: Opportunity Beyond Defence

    Opportunity Beyond Defence Civilian adoption is gated by scalable supply not demand › Consumer electronics: Samsung, LG and Murata have explored MXene electrodes to replace brittle ITO in displays; EMI shielding for densely packed 5G devices › Energy storage: Supercapacitors and fast-charging microb

  15. Slide 15: Medium-Term Potential Markets

    Medium-Term Potential Markets Opportunity of adoption in large commercial markets Electronics1 Water Treatment2 › Matches copper shielding at 1/20th the thickness, › Raises PFAS rejection from 72% to over 96% protecting electronics without extra bulk or weight › Captures short-chain PFAS that slip t

  16. Slide 16: ECT's Technology Portfolio

    ECT’s Technology Portfolio The MXene licence adds to ECT’s growing portfolio of innovative, scalable technologies MXenes via FJH (following completion of the Xenica acquisition) NEW Exclusive licence to synthesise MXenes and 2D amorphous carbon using Flash Joule Heating REM IN TESTING Rapid Electrot

  17. Slide 17: Capital Table, Sources & Uses

    Capital Table, Sources & Uses Ownership Post-Raise SOURCES OF FUNDS $m 19.3% Existing Shareholders Placement $12.0m Vendor Shares 11.6% TOTAL SOURCES $12.0m Placement Shares 69.2% USES OF FUNDS $m Development of new technology (FJH for MXenes) $4.5m SHARES % Development of existing technologies (FJH

  18. Slide 18: Thank You

    Thank You • MARKET OPPORTUNITY • CONTACT ECT has undertaken corporate consolidation with a focus on a renewed strategy for structural realignment. Faldi Ismail CONTACT Stephanie Richardson However, future value will be driven by: EMAIL info@ectltd.com.au EMAIL stephanie.richardson@sodali.com ASX:ECT

Environmental Clean Technologies — Merger or Acquisition (August 2026) on 6ix